DRREDDY

Dr. Reddy’s is benefiting from a strong product pipeline, launch momentum in the US generics market, and expanding presence in emerging markets. The company’s focus on biosimilars, injectables, and specialty products supports margin expansion. Cost efficiency initiatives and operational discipline help navigate pricing pressure in regulated markets.